JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$2.94B
| $2.1M | ﹤0.01% |
41,422
+251
| +0.6% | +$12.7K |
2017 Q1
3 quarters
|
|
3152
Regional Management Corp
RM
$291M
| $2.1M | ﹤0.01% |
79,771
-37,079
| -32% | -$907K |
2016 Q4
4 quarters
|
|
|
PRTY
3153
CALL
DELISTED
Party City Holdco Inc.
PRTY
| $2.09M | ﹤0.01% |
+150,000
| New | +$1.85M |
2017 Q4
0 quarters
|
|
|
RBS.PRS.CL
3154
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $2.09M | ﹤0.01% |
82,098
-173,932
| -68% | -$4.46M |
2017 Q3
1 quarter
|
|
|
LL
3155
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.08M | ﹤0.01% |
66,192
+65,799
| +16,743% | +$2.08M |
2015 Q4
8 quarters
|
|
|
JNCE
3156
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.07M | ﹤0.01% |
162,723
+120,523
| +286% | +$1.77M |
2017 Q1
3 quarters
|
|
3157
Encore Capital Group
ECPG
$2.08B
| $2.06M | ﹤0.01% |
49,007
-20,081
| -29% | -$917K |
2013 Q2
18 quarters
|
|
|
ECHO
3158
EchoStar
ECHO
$26.7B
| $2.06M | ﹤0.01% |
42,463
+40,896
| +2,610% | +$1.9M |
2017 Q3
1 quarter
|
|
|
RRD
3159
DELISTED
RR Donnelley & Sons Co.
RRD
| $2.05M | ﹤0.01% |
220,794
+62,875
| +40% | +$574K |
2016 Q4
4 quarters
|
|
3160
PUT
Visa
V
$676B
| $2.05M | ﹤0.01% |
18,000
| – | – |
2017 Q2
2 quarters
|
|
3161
PUT
Tronox
TROX
$632M
| $2.05M | ﹤0.01% |
+100,000
| New | +$2.44M |
2017 Q4
0 quarters
|
|
3162
Diodes
DIOD
$4.75B
| $2.05M | ﹤0.01% |
71,512
+42,391
| +146% | +$1.32M |
2013 Q2
18 quarters
|
|
3163
Compass Minerals
CMP
$938M
| $2.04M | ﹤0.01% |
28,295
+20,827
| +279% | +$1.4M |
2015 Q4
8 quarters
|
|
|
UCFC
3164
DELISTED
United Community Financial Corp
UCFC
| $2.04M | ﹤0.01% |
223,372
-23,479
| -10% | -$223K |
2014 Q4
12 quarters
|
|
3165
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.56B
| $2.03M | ﹤0.01% |
67,554
-530
| -0.8% | -$15.6K |
2013 Q2
18 quarters
|
|
3166
CALL
PACCAR
PCAR
$58B
| $2.03M | ﹤0.01% |
+42,900
| New | +$2.03M |
2017 Q4
0 quarters
|
|
|
3167
PUT
PACCAR
PCAR
$58B
| $2.03M | ﹤0.01% |
+42,900
| New | +$2.03M |
2017 Q4
0 quarters
|
|
3168
PJT Partners
PJT
$3.61B
| $2.03M | ﹤0.01% |
44,533
-8,847
| -17% | -$360K |
2015 Q4
8 quarters
|
|
3169
Ares Management
ARES
$27.4B
| $2.03M | ﹤0.01% |
101,412
-106,406
| -51% | -$1.99M |
2016 Q4
4 quarters
|
|
3170
GDS Holdings
GDS
$5.74B
| $2.03M | ﹤0.01% |
89,968
+54,645
| +155% | +$965K |
2017 Q1
3 quarters
|
|
3171
CALL
American Express
AXP
$204B
| $2.03M | ﹤0.01% |
20,400
-4,700
| -19% | -$448K |
2016 Q3
5 quarters
|
|
3172
PUT
Halozyme
HALO
$12.3B
| $2.03M | ﹤0.01% |
+100,000
| New | +$1.84M |
2017 Q4
0 quarters
|
|
|
ESIO
3173
DELISTED
Electro Scientific Industries
ESIO
| $2.02M | ﹤0.01% |
94,460
+86,622
| +1,105% | +$1.74M |
2017 Q3
1 quarter
|
|
3174
iShares MSCI Germany ETF
EWG
$1.5B
| $2.02M | ﹤0.01% |
61,273
-434
| -0.7% | -$14.3K |
2013 Q2
18 quarters
|
|
3175
Vanguard Morningstar Mega Cap Growth ETF
MGK
$35.1B
| $2.02M | ﹤0.01% |
90,860
+40,280
| +80% | +$877K |
2016 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.